The ocean is home to more biodiversity than anywhere else on the planet—making it a largely untapped source of opportunity for researchers studying marine organisms as a source of novel drug... Read more »
Startup nference has closed a $60 million Series B financing round to expand the use of its augmented intelligence platform in clinical research and drug development.
Mayo Clinic and NTT Venture... Read more »
The Department of Defense has awarded Adaptive Phage Therapeutics a $10.2 million contract to help advance its experimental therapy for the treatment of multidrug-resistant infections.
Gaithersburg, MD-based Adaptive Phage Therapeutics (APT)... Read more »
Insilico Medicine on Tuesday announced that it has entered a research collaboration with Pfizer, which Insilico CEO Alex Zhavoronkov says has “one of the most advanced AI teams internally both in... Read more »
The genetic testing company NeoGenomics has acquired Human Longevity’s oncology division, which provides next-generation sequencing services.
The division of San Diego-based Human Longevity generated approximately $10 million in revenue in 2019—an... Read more »
Continuing to make headlines in the neurodegenerative disease space, Biogen on Monday announced a deal to acquire a clinical-stage Pfizer asset that has potential applications in Alzheimer’s and Parkinson’s disease, for... Read more »
Roche will pay Amunix Pharmaceuticals $40 million up front to use the company’s proprietary technology to discover and develop new drugs outside of the oncology space.
The clinically validated platform—XTEN—is a... Read more »
Investors pumped £2.8 billion ($3.67 billion) into UK-based startups between 2014-2018, marking a four-fold increase from the previous five-year time period, according to a report published by the Nottingham-based incubator, BioCity.... Read more »
Novo Holdings is repositioning the strategic focus of its REPAIR Fund in order to provide later-stage support to its portfolio companies, as the struggling antibiotics industry faces a dearth of investment.... Read more »
Takeda is teaming up with MIT to advance projects intended to enhance its understanding of how to best use artificial intelligence to solve some of the biopharma industry’s biggest challenges.
The... Read more »
The China-based pharmaceutical company CF PharmTech has raised $90 million to support its pipeline of respiratory drugs.
The Series E investment round was led by New Alliance Capital. New investors CR-CP... Read more »
Wave Life Sciences’ stock took another plunge after the company reported early results from its Huntington’s disease study.
Cambridge, MA-based Wave Life Sciences (NASDAQ: WVE) earlier this week released topline... Read more »
Partnering and sharing data will improve the research and development process for all pharmaceutical industry stakeholders, of which there are more than ever, according to a top executive at Evotec.
“Imagine... Read more »
2020 will be a big year for ArcherDX, says its CEO on the heels of raising $55 million to advance its companion diagnostics platform—which is intended to make precision medicine an... Read more »
More than 250 miles above the Earth’s surface aboard the International Space Station, a first-in-kind study of neurodegenerative disease is expected to reveal never-before-seen cell interactions.
The National Stem Cell Foundation... Read more »
The ALS Investment Fund has teamed with the ALS Association and is looking to establish new partnerships as part of its efforts to raise $100 million and collate a diversified set... Read more »
Wave Life Sciences saw its stock price plunge nearly 60 percent Monday following the company’s decision to discontinue development of its investigational Duchenne muscular dystrophy drug, suvodirsen, after an interim analysis... Read more »
Charles River Laboratories International is making moves in the cell therapy space after signing on the cell reprogramming startup Bit Bio and announcing plans to acquire a biomaterials company for $380... Read more »
GE Healthcare Life Sciences and ASLS have teamed up to offer a new platform that can design, build, and image living 3D tissue models for drug discovery and development.
ASLS, Advanced... Read more »
Zentalis Pharmaceuticals is banking on small molecules for cancer—leaving the “cool technologies” aside for a “tried and true” approach, says the CEO, who wants to let the science speak for itself.... Read more »